TEVA - GSK Teva AstraZeneca under Senate probe over asthma inhaler pricing
2024-01-08 15:45:47 ET
More on AstraZeneca, GSK, etc.
- Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win
- AbbVie Vs. GSK: Dual Dominance In Pharma
- GSK - Greenshoots In The Horizon
- FDA evaluating reports of GLP-1 drugs and negative side effects
- Piper Sandler raises Teva to neutral, stock up 4%
For further details see:
GSK, Teva, AstraZeneca under Senate probe over asthma inhaler pricing